• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: JOHNSON & JOHNSON CONSUMER INC NEUTROGENA STUBBORN ACNE ULTRA THIN BLEMISH PATCH; DRESSING, WOUND, OCCLUSIVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

JOHNSON & JOHNSON CONSUMER INC NEUTROGENA STUBBORN ACNE ULTRA THIN BLEMISH PATCH; DRESSING, WOUND, OCCLUSIVE Back to Search Results
Model Number 070501064375
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Hypersensitivity/Allergic reaction (1907)
Event Type  Injury  
Manufacturer Narrative
Johnson & johnson consumer, inc.Is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which johnson & johnson consumer, inc.Has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, johnson & johnson consumer, inc.Or its employees that the report constitutes an admission that the device, johnson & johnson consumer, inc., or its employees caused or contributed to the potential event described in this report.Device was used for treatment, not diagnosis.A4, a5: weight, and ethnicity and race were not provided for reporting.D1, d2, d3, d4: this report is for one (neutrogena stubborn acne ultra thin blemish patch assorted 16ct usa 070501064375 (b)(6), lot/ctrl # 2422c).D4: udi #: (b)(4).Upc #: 070501064375 lot #: 2422c exp date: na d9: device is not expected to be returned for manufacturer review/investigation.H3, h4, h6: device evaluation/investigation could not be completed; no conclusion could be drawn as product was not returned to manufacturer.Device history records review has been requested.H6: health effect clinical code: e0402 also refers to consumer alleged for "allergic reaction and face turned red and broke out".This is one of five medwatches being submitted as five devices were involved in this event.See medwatches 2214133-2024-00010; 2214133-2024-00011; 2214133-2024-00012; 2214133-2024-00013; 2214133-2024-00014.The same patient and event is represented in each medwatch.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Event Description
A male consumer reported an allergic reaction with neutrogena stubborn acne ultra thin blemish patches assorted.It was reported that consumer applied five circles one time, five weeks ago on his face for minor blemishes and it caused an immediate allergic reaction.Consumer reported that his face turned red and broke out.Consumer sought medical intervention and was treated with an unspecified antibiotic for three weeks.Consumer¿s symptoms have worsened at the time of this reporting.This is one of five medwatches being submitted as five devices were involved in this event.See medwatches 2214133-2024-00010; 2214133-2024-00011; 2214133-2024-00012; 2214133-2024-00013; 2214133-2024-00014.The same patient and event is represented in each medwatch.
 
Manufacturer Narrative
Johnson & johnson consumer, inc.Is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which johnson & johnson consumer, inc.Has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, johnson & johnson consumer, inc.Or its employees that the report constitutes an admission that the device, johnson & johnson consumer, inc., or its employees caused or contributed to the potential event described in this report.Device was used for treatment, not diagnosis.Device history records review was completed.No non-conformance reports were generated during production.Review of the device history records showed that there were no issues during the manufacture of the product that would contribute to this complaint condition and product was manufactured per specification.The product was manufactured on march 23, 2022.This is one of five follow-up medwatches being submitted as five devices were involved in this event.See medwatches 2214133-2024-00011; 2214133-2024-00012; 2214133-2024-00013; 2214133-2024-00014.The same patient and event is represented in each medwatch.If information is obtained that was not available for the follow-up medwatch, an additional follow- up medwatch will be filed as appropriate.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NEUTROGENA STUBBORN ACNE ULTRA THIN BLEMISH PATCH
Type of Device
DRESSING, WOUND, OCCLUSIVE
Manufacturer (Section D)
JOHNSON & JOHNSON CONSUMER INC
199 grandview road
skillman NJ 08558 9418
Manufacturer (Section G)
COLOPLAST
coloplast hungary kft
h-4300 nyirbator
coloplast
HU  
Manufacturer Contact
michael connaughton
199 grandview rd
skillman, NJ 08558-9418
9086555919
MDR Report Key18950197
MDR Text Key338250433
Report Number2214133-2024-00010
Device Sequence Number1
Product Code NAD
UDI-Device Identifier070501064375
UDI-Public(01)070501064375(10)2422C
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 03/21/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/21/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model Number070501064375
Device Lot Number2422C
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Event Location Other
Date Manufacturer Received03/21/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/23/2022
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient SexMale
-
-